Septic Shock: Clinical Trials

8 trials for Septic Shock, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 recruiting. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Recruiting 8
Phase 21Recruiting 1

Follow Septic Shock: new trials by email Literature Review of Septic Shock trials Research Report on Septic Shock

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial of Adjunctive Fludrocortisone (50mcg, 100mcg or Placebo) in Critically Ill Patients With Septic Shock Receiving Hydrocortisone, Evaluating Survival and Functional Recovery and the Influence of Transcriptomic Response
Fludrocortisone 50 mcg daily, Fludrocortisone 100 mcg daily, Placebo - Septic Shock
Phase 3RecruitingThe George Institute22002026-10-162026-10-30
Systematic Adjunction of Vasopressine in Septic Shock
Vasopressin administration, Sodium chloride administration - Septic Shock
Phase 3RecruitingAssistance Publique Hopitaux De Marseille1202026-03-242026-10-26
Early Methylene Blue in the Microhemodynamics of Septic Patients
Methylene blue infusion - Septic Shock, Hypoperfusion
Phase 2 / Phase 3RecruitingCentro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva502026-01-092026-03-27
Weaning Approaches for Vasopressin in Sepsis
Titrated weaning of vasopressin., Abrupt weaning of vasopressin. - Septic Shock
Phase 3RecruitingHospital Nossa Senhora da Conceicao822025-10-012026-01-02
Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis
Early Vasopressin, Norepinephrine and Vasopressin for Rescue - Septic Shock
Phase 3RecruitingHospital do Coracao28002024-11-212026-01-30
LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)
Landiolol - Septic Shock
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris442022-07-182025-08-01
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility
echocardiography, Landiolol - Septic Shock, Tachycardia
Phase 3RecruitingCentre Hospitalier Universitaire, Amiens3602021-02-012025-08-24
Stress Hydrocortisone In Pediatric Septic Shock
Hydrocortisone, sodium succinate, Normal saline - Septic Shock
Phase 3RecruitingJerry Zimmerman5002019-03-112025-10-30

Narrower conditions

Shock, Septic (8)  ·  Diabetes Insipidus (2)  ·  Sepsis (2)  ·  Critical Illness (1)  ·  Tachycardia (1)

Broader conditions

Infections (8)  ·  Inflammation (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Shock (8)  ·  Systemic Inflammatory Response Syndrome (8)  ·  Sepsis (6)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Pituitary Diseases (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)

Interventions

landiolol (2)  ·  Fludrocortisone (1)  ·  Hydrocortisone (1)  ·  Methylene Blue (1)  ·  Norepinephrine (1)  ·  Phenothiazines (1)  ·  Saline Solution (1)  ·  Vasopressins (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva (1)  ·  Hospital Nossa Senhora da Conceicao (1)  ·  Hospital do Coracao (1)  ·  Jerry Zimmerman (1)  ·  The George Institute (1)

Countries

Brazil (4)  ·  France (3)  ·  Australia (1)  ·  Canada (1)  ·  Israel (1)  ·  Japan (1)  ·  Malaysia (1)  ·  Pakistan (1)  ·  Saudi Arabia (1)  ·  Singapore (1)  ·  United States (1)  ·  Vietnam (1)

Top investigators

Bruno M Tomazini, MD (1)  ·  David Wypij, PhD (1)  ·  Jerry J Zimmerman MD, MD, PhD (1)  ·  Kusum Menon, MD, MSc (1)  ·  Machado R Flavia, PhD (1)  ·  Michael Agus, MD (1)  ·  Mihir R Atreya, MD, MPH (1)

Results publications

PMID 19926252, PMID 28750598, PMID 28861671, PMID 29328496, PMID 29784057, PMID 30798676, PMID 31958982, PMID 32842024, PMID 35331049, PMID 36621622, PMID 38213315, PMID 38240508, PMID 40310269, PMID 41504572, PMID 41504575, PMID 9054839

NIH funding

R01HD096901 (1)